Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Mason

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Brain Research. Molecular Brain Research|October 1, 1990
Induction of Fos-like immunoreactivity and the maintenance of long-term potentiation in the dentate gyrus of unanesthetized ratsK J Jeffery, W C Abraham, M Dragunow, et al.
Archives of General Psychiatry|February 1, 1994
Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trialS G Siris, P C Bermanzohn, S E Mason, et al.
AJR. American Journal of Roentgenology|January 1, 1978
Popliteal vein thrombosis secondary to popliteal artery aneurysmP E Giustra, J A Root, S E Mason, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Antidepressant for substance-abusing schizophrenic patients: a minireviewS G Siris, P C Bermanzohn, S E Mason, et al.
Chest|February 1, 1988
Total lung capacity. An insensitive measure of impairment in patients with asbestosis and chronic obstructive pulmonary disease?S Barnhart, L D Hudson, S E Mason, et al.
Brain Research. Molecular Brain Research|June 1, 1997
TrkB expression in dentate granule cells is associated with a late phase of long-term potentiationM Dragunow, P Hughes, S E Mason-Parker, et al.
Brain Research. Molecular Brain Research|September 28, 1998
Biphasic changes in the levels of N-methyl-D-aspartate receptor-2 subunits correlate with the induction and persistence of long-term potentiationJ M Williams, S E Mason-Parker, W C Abraham, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1992
Adjunctive imipramine for dysphoric schizophrenic patients with past histories of cannabis abuseS G Siris, P C Bermanzohn, S E Mason, et al.
Psychopharmacology Bulletin|January 1, 1992
Continuation treatment with adjunctive imipramine in schizophreniaS G Siris, P C Bermanzohn, S E Mason, et al.
Psychopharmacology Bulletin|January 1, 1993
Adjunctive imipramine in substance-abusing dysphoric schizophrenic patientsS G Siris, S E Mason, P C Bermanzohn, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Brain Research. Molecular Brain Research|October 1, 1990
Induction of Fos-like immunoreactivity and the maintenance of long-term potentiation in the dentate gyrus of unanesthetized ratsK J Jeffery, W C Abraham, M Dragunow, et al.
Archives of General Psychiatry|February 1, 1994
Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trialS G Siris, P C Bermanzohn, S E Mason, et al.
AJR. American Journal of Roentgenology|January 1, 1978
Popliteal vein thrombosis secondary to popliteal artery aneurysmP E Giustra, J A Root, S E Mason, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Antidepressant for substance-abusing schizophrenic patients: a minireviewS G Siris, P C Bermanzohn, S E Mason, et al.
Chest|February 1, 1988
Total lung capacity. An insensitive measure of impairment in patients with asbestosis and chronic obstructive pulmonary disease?S Barnhart, L D Hudson, S E Mason, et al.
Brain Research. Molecular Brain Research|June 1, 1997
TrkB expression in dentate granule cells is associated with a late phase of long-term potentiationM Dragunow, P Hughes, S E Mason-Parker, et al.
Brain Research. Molecular Brain Research|September 28, 1998
Biphasic changes in the levels of N-methyl-D-aspartate receptor-2 subunits correlate with the induction and persistence of long-term potentiationJ M Williams, S E Mason-Parker, W C Abraham, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1992
Adjunctive imipramine for dysphoric schizophrenic patients with past histories of cannabis abuseS G Siris, P C Bermanzohn, S E Mason, et al.
Psychopharmacology Bulletin|January 1, 1992
Continuation treatment with adjunctive imipramine in schizophreniaS G Siris, P C Bermanzohn, S E Mason, et al.
Psychopharmacology Bulletin|January 1, 1993
Adjunctive imipramine in substance-abusing dysphoric schizophrenic patientsS G Siris, S E Mason, P C Bermanzohn, et al.
Pageof 5